Givaudan reports 5.20 percent growth. Givaudan stock is valued at CHF 36.6 billion

Published on 10/23/2026 at 10:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Nine-month sales rose 5.20 percent LFL to CHF 5,891 million in 2026. Givaudan stock costs EUR 4,291.50 on October 23, 2026 at a CHF 36.6 billion market value.

Sales and valuation context

Givaudan reported 5.20 percent like-for-like sales growth for the first nine months on October 13, 2026.
UBS lifted its price target to CHF 3,960.00 while keeping a Neutral rating on October 16, 2026.
Givaudan stock trades at EUR 4,291.50 at 10:15 a.m. CEST at Lang & Schwarz on October 23, 2026.

A financial editorial photograph of a large stock exchange monitor. The screen displays rising green financial charts and numeric price data. A bright green LED ticker banner reads FLAVOR & FRAGRANCE SPECIALTY SIX SWISS. The background shows a blurred tra — Givaudan CH0010645932 Börsenmonitor mit FLAVOR FRAGRANCE SPECIALTY SIX SWISS Text und steigender grüner Kursgrafik, Illustration mit AI erstellt.

Givaudan (ISIN CH0010645932) was trading at EUR 4,291.50 at Lang & Schwarz on October 23, 2026 at 10:15 a.m. CEST, with a market capitalization of CHF 36.6 billion. The company reported accelerating sales growth for the first nine months of 2026 in a release dated October 13, 2026, according to Givaudan.

Sales growth reaches 5.20 percent

Givaudan recorded CHF 5,891 million in sales for the first nine months of 2026, up 5.20 percent on a like-for-like basis from 5.70 percent in the comparable 2025 period, the company said. Fragrance and Beauty sales rose 8.80 percent like for like to CHF 3,150 million, while Taste and Wellbeing increased 1.50 percent to CHF 2,741 million.

The third quarter was stronger than the nine-month average. Group sales reached CHF 2,092 million, up 8.60 percent like for like from 4.40 percent in the third quarter of 2025, with Fragrance and Beauty growing 13.50 percent.

Three dated steps shaped valuation

On October 13, 2026, Givaudan reported CHF 5,891 million in nine-month sales and 5.20 percent like-for-like growth, according to Givaudan. On October 16, 2026, UBS raised its target from CHF 3,270.00 to CHF 3,960.00 and kept its Neutral rating, according to MarketScreener. On October 20, 2026, Bernstein retained a Sell rating with a CHF 3,004.00 target, according to MarketScreener.

What does the target split mean?

The analyst range shows how sharply views differ after the sales update. UBS cited rising expectations after the recent performance, while Bernstein kept its CHF 3,004.00 target despite the stronger third-quarter growth. Givaudan also said higher input costs were being offset through customer price increases in 2026.

Two dates remain ahead

Givaudan lists an investor presentation in Zurich for October 29, 2026, according to Givaudan. The company has scheduled its full-year 2026 results for January 27, 2027, the same release states.

Stock trades at a high valuation

Givaudan combines accelerating Fragrance and Beauty growth with weaker North American conditions, where nine-month like-for-like sales fell 3.30 percent. That contrast leaves the next company update important for judging whether recent growth can broaden beyond fragrances.

Givaudan was trading at EUR 4,291.50 at Lang & Schwarz on October 23, 2026 at 10:15 a.m. CEST. Its primary listing is on the SIX Swiss Exchange, where the quoted share price was CHF 3,960.00 at 8:12 a.m. CEST on October 23, 2026.

The further course of trading is shown by the continuously updated real-time quote of Givaudan stock.